Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease

Matteo Cotta Ramusino,Valentina Garibotto,Ruggero Bacchin,Daniele Altomare,Alessandra Dodich,Frédéric Assal,Aline Mendes,Alfredo Costa,Michele Tinazzi,Silvia Morbelli,Matteo Bauckneht,Agnese Picco,Massimo E. Dottorini,Cristina Tranfaglia,Lucia Farotti,Nicola Salvadori,Davide V. Moretti,Giordano Savelli,Anna Tarallo,Flavio Nobili,Maura Parapini,Carlo Cavaliere,Elena Salvatore,Marco Salvatore,Marina Boccardi,Giovanni B. Frisoni

Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease

2019

Purpose To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-tau) in AD diagnosis in patients with mild cognitive impairment (MCI) or mild dementia, in order to improve the definition of diagnostic algorithm.

Keywords:

Medicine
Disease
Mild dementia
Radiology
Amyloid
Cognition
Positron emission tomography
Cerebrospinal fluid
Biomarker (medicine)
amyloid pet
Dementia
Internal medicine
Neuropsychology
Etiology
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations